Tributary Capital Management, LLC
Q2 2014 13F-HR Holdings
Net value change ($000)
+24,788
(5.2%)
New positions
36
Sold out positions
10
Turnover %
10.8%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2014
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| DHI | 3,881 | NEW |
| FLYYQ | 3,830 | NEW |
| NEW RITE AID, LLC | 3,596 | NEW |
| TRS | 3,186 | NEW |
| GTLS | 3,177 | NEW |
| GENOMIC HEALTH INC | 2,731 | NEW |
| ANALOGIC CORP | 2,439 | NEW |
| URI | 1,916 | 65.8% |
| QUESTCOR PHARMACEUTICALS INC COM | 1,847 | 42.4% |
| VRTS | 1,829 | 80.5% |
Top Reduces (Value $000, Stocks/ETFs)
| CSL | -3,846 | -100.0% |
| PDL BIOPHARMA, INC. | -3,180 | -100.0% |
| WWD | -3,058 | -100.0% |
| PSMT | -2,967 | -100.0% |
| WERN | -2,962 | -100.0% |
| SNYDERS-LANCE INC | -2,369 | -100.0% |
| VRE | -2,326 | -100.0% |
| ZTS | -2,119 | -66.6% |
| HUBG | -1,810 | -100.0% |
| NEUSTAR INC | -1,574 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|